Mesenchymal Stem Cell-Derived Secretome and Extracellular Vesicles Attenuate Progression of Inflammation and Cartilage Destruction in Inflammatory Arthritis - Oksana Kehoe (Keele University)

12:00pm - 1:00pm / Monday 19th February 2018 / Venue: Lecture Theatre 1 Life Sciences Building
Type: Seminar / Category: Research / Series: GSTT Seminar Series
  • Suitable for: Staff/students with an interest in Genomes, Systems and Therapeutic Targeting
  • Admission: Free
  • Add this event to my calendar

    When you click on "Add this event to my calendar" your browser will download an ics file.

    Microsoft Outlook: Download the file, then you may be able to click on "Save & Close" to save it to your calendar. If that doesn't work go into Outlook, click on the File tab, then on Open, then Import. Select "Import an iCalendar (.ic or vCalendar file (.vcs)" then click on Next. Find the .ics file and click on OK.

    Google Calendar: download the file, then go into your calendar. On the right where it says "Other calendars" click on the arrow icon and then click on Import calendar. Click on Browse and select the .ics file, then click on Import.

    Apple Calendar: download the file, then you can either drag it to Calendar or import the file by going to File > Import > Import and choosing the .ics file.

Rheumatoid arthritis (RA) is a debilitating and painful disorder affecting more than 690,000 people in the UK, with 12,000 new cases diagnosed annually. Novel biological therapies have revolutionised the management of RA. However, up to 30% of RA patients fail to respond to currently available biological therapeutics and 50% of those prescribed the treatment discontinue use after 2 years. It is therefore vital to develop a new, effective therapy for RA. Mesenchymal stem cells (MSCs) possess anti-inflammatory and immunosuppressive properties that may be exploited therapeutically. We have previously demonstrated that intra-articular) injection of MSCs reduces inflammation and cartilage damage in antigen-induced arthritis (AIA). In my presentation, I will discuss data from our lab for the application of MSCs-derived secretome and extracellular vesicles in inflammatory arthritis.